Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Legault Pierre Create: Alert

All | News | Filings
Date FiledTypeDescription
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/09/2022 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Sold 10,000 shares @ $23.0159, valued at $230.2k
Sold 14,000 shares @ $23.0159, valued at $322.2k
Exercised 10,000 options to buy @ $9.63, valued at $96.3k
Exercised 14,000 options to buy @ $8.93, valued at $125k
02/03/2022 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 16,000 shares @ $0
01/05/2022 4 Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 10,000 shares @ $0
Granted 20,000 options to buy @ $60.87, valued at $1.2M
12/22/2021 4 Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Exercised 7,603 shares @ $8.41, valued at $63.9k
Sold 7,603 shares @ $57.02, valued at $433.5k
Exercised 44,537 shares @ $8.44, valued at $375.9k
Sold 44,537 shares @ $57.11, valued at $2.5M
Exercised 97,860 shares @ $8.48, valued at $829.9k
Sold 97,860 shares @ $58.01, valued at $5.7M
Exercised 7,603 options to buy @ $0
Exercised 44,537 options to buy @ $0
Exercised 97,860 options to buy @ $0
12/22/2021 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Sold 20,000 shares @ $21.0125, valued at $420.3k
Sold 24,000 shares @ $22.0086, valued at $528.2k
Exercised 20,000 options to buy @ $7.08, valued at $141.6k
Exercised 24,000 options to buy @ $7.88, valued at $189.1k
04/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Exercised 10,000 shares @ $8.78, valued at $87.8k
Sold 10,000 shares @ $30, valued at $300k
Exercised 10,000 options to buy @ $0
03/31/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/23/2020 4 Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 9,000 shares @ $0
Granted 15,000 options to buy @ $9.38, valued at $140.7k
04/27/2020 4/A Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 116,827 options to buy @ $14, valued at $1.6M
02/14/2020 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 24,000 options to buy @ $9.47, valued at $227.3k
01/14/2020 4 Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 12,480 shares @ $0
01/06/2020 4 Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 32,000 options to buy @ $9.82, valued at $314.2k
07/11/2019 4 Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 25,000 options to buy @ $8.78, valued at $219.5k
06/12/2019 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 24,000 options to buy @ $7.88, valued at $189.1k
05/30/2019 4 Legault Pierre (Director) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 116,827 options to buy @ $14, valued at $1.6M
05/22/2019 3 Legault Pierre (Director) has filed a Form 3 on BICYCLE THERAPEUTICS Ltd
05/07/2019 3 Legault Pierre (Director) has filed a Form 3 on Alliqua BioMedical, Inc.
11/26/2018 4 Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.
Txns: Granted 36,650 options to buy @ $8.01, valued at $293.6k
09/26/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
06/22/2018 4 Legault Pierre (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Disposed/sold 18,000 options to buy @ $39.97, valued at $719.5k
Disposed/sold 55,765 options to buy @ $6.7343, valued at $375.5k
05/25/2018 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 14,000 options to buy @ $8.93, valued at $125k
03/28/2018 4 Legault Pierre (Director) has filed a Form 4 on ARMO BioSciences, Inc.
Txns: Granted 18,000 options to buy @ $39.97, valued at $719.5k
02/12/2018 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 10,000 options to buy @ $9.63, valued at $96.3k
01/25/2018 3 Legault Pierre (Director) has filed a Form 3 on ARMO BioSciences, Inc.
05/19/2017 4 Legault Pierre (Director) has filed a Form 4 on Syndax Pharmaceuticals Inc
Txns: Granted 10,000 options to buy @ $13.58, valued at $135.8k
Granted 5,000 options to buy @ $13.58, valued at $67.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy